MDR-TB in Eastern Europe in the era of the TB elimination action framework

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):2-3. doi: 10.5588/ijtld.16.0732.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use*
  • Drug Resistance, Multiple, Bacterial*
  • Health Services Accessibility*
  • Healthcare Disparities
  • Humans
  • Moldova / epidemiology
  • Prognosis
  • Risk Factors
  • Tuberculosis, Multidrug-Resistant / diagnosis
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Ukraine / epidemiology

Substances

  • Antitubercular Agents